Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9AW89
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0005525 | GTP binding | 5 | 10 |
GO:0017076 | purine nucleotide binding | 4 | 10 |
GO:0019001 | guanyl nucleotide binding | 5 | 10 |
GO:0032553 | ribonucleotide binding | 3 | 10 |
GO:0032555 | purine ribonucleotide binding | 4 | 10 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 10 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 10 |
GO:0036094 | small molecule binding | 2 | 10 |
GO:0043167 | ion binding | 2 | 10 |
GO:0043168 | anion binding | 3 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:0097367 | carbohydrate derivative binding | 2 | 10 |
GO:1901265 | nucleoside phosphate binding | 3 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 295 | 299 | PF00656 | 0.653 |
CLV_C14_Caspase3-7 | 356 | 360 | PF00656 | 0.350 |
CLV_C14_Caspase3-7 | 81 | 85 | PF00656 | 0.432 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.465 |
CLV_NRD_NRD_1 | 266 | 268 | PF00675 | 0.597 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.417 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.452 |
CLV_PCSK_KEX2_1 | 139 | 141 | PF00082 | 0.760 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.368 |
CLV_PCSK_KEX2_1 | 265 | 267 | PF00082 | 0.576 |
CLV_PCSK_KEX2_1 | 322 | 324 | PF00082 | 0.325 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.467 |
CLV_PCSK_PC1ET2_1 | 139 | 141 | PF00082 | 0.775 |
CLV_PCSK_PC1ET2_1 | 322 | 324 | PF00082 | 0.320 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.501 |
CLV_PCSK_PC7_1 | 261 | 267 | PF00082 | 0.346 |
CLV_PCSK_SKI1_1 | 110 | 114 | PF00082 | 0.481 |
CLV_PCSK_SKI1_1 | 142 | 146 | PF00082 | 0.601 |
CLV_PCSK_SKI1_1 | 217 | 221 | PF00082 | 0.204 |
CLV_PCSK_SKI1_1 | 270 | 274 | PF00082 | 0.537 |
CLV_PCSK_SKI1_1 | 319 | 323 | PF00082 | 0.328 |
CLV_PCSK_SKI1_1 | 51 | 55 | PF00082 | 0.372 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.442 |
DEG_APCC_DBOX_1 | 50 | 58 | PF00400 | 0.368 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.454 |
DEG_SCF_FBW7_1 | 127 | 134 | PF00400 | 0.563 |
DEG_SPOP_SBC_1 | 35 | 39 | PF00917 | 0.611 |
DOC_CKS1_1 | 195 | 200 | PF01111 | 0.468 |
DOC_CKS1_1 | 232 | 237 | PF01111 | 0.419 |
DOC_CYCLIN_yClb1_LxF_4 | 206 | 212 | PF00134 | 0.427 |
DOC_MAPK_DCC_7 | 167 | 176 | PF00069 | 0.517 |
DOC_MAPK_MEF2A_6 | 167 | 176 | PF00069 | 0.413 |
DOC_PP1_RVXF_1 | 70 | 77 | PF00149 | 0.425 |
DOC_USP7_UBL2_3 | 145 | 149 | PF12436 | 0.603 |
DOC_WW_Pin1_4 | 127 | 132 | PF00397 | 0.708 |
DOC_WW_Pin1_4 | 152 | 157 | PF00397 | 0.545 |
DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.524 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.431 |
DOC_WW_Pin1_4 | 275 | 280 | PF00397 | 0.566 |
DOC_WW_Pin1_4 | 415 | 420 | PF00397 | 0.485 |
LIG_14-3-3_CanoR_1 | 110 | 115 | PF00244 | 0.528 |
LIG_14-3-3_CanoR_1 | 179 | 187 | PF00244 | 0.431 |
LIG_14-3-3_CanoR_1 | 267 | 275 | PF00244 | 0.614 |
LIG_14-3-3_CanoR_1 | 379 | 387 | PF00244 | 0.379 |
LIG_14-3-3_CanoR_1 | 72 | 77 | PF00244 | 0.485 |
LIG_Actin_WH2_2 | 188 | 205 | PF00022 | 0.468 |
LIG_BIR_III_2 | 359 | 363 | PF00653 | 0.387 |
LIG_BRCT_BRCA1_1 | 207 | 211 | PF00533 | 0.480 |
LIG_Clathr_ClatBox_1 | 218 | 222 | PF01394 | 0.499 |
LIG_eIF4E_1 | 338 | 344 | PF01652 | 0.409 |
LIG_eIF4E_1 | 372 | 378 | PF01652 | 0.400 |
LIG_FHA_1 | 204 | 210 | PF00498 | 0.466 |
LIG_FHA_1 | 232 | 238 | PF00498 | 0.391 |
LIG_FHA_1 | 308 | 314 | PF00498 | 0.547 |
LIG_FHA_1 | 387 | 393 | PF00498 | 0.341 |
LIG_FHA_1 | 84 | 90 | PF00498 | 0.453 |
LIG_FHA_2 | 354 | 360 | PF00498 | 0.320 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.412 |
LIG_GBD_Chelix_1 | 187 | 195 | PF00786 | 0.324 |
LIG_LIR_Apic_2 | 345 | 350 | PF02991 | 0.482 |
LIG_LIR_Gen_1 | 337 | 347 | PF02991 | 0.354 |
LIG_LIR_Gen_1 | 418 | 425 | PF02991 | 0.435 |
LIG_LIR_Nem_3 | 197 | 202 | PF02991 | 0.533 |
LIG_LIR_Nem_3 | 208 | 214 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 337 | 343 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 418 | 424 | PF02991 | 0.470 |
LIG_LIR_Nem_3 | 56 | 61 | PF02991 | 0.376 |
LIG_PCNA_yPIPBox_3 | 184 | 196 | PF02747 | 0.431 |
LIG_PDZ_Class_1 | 420 | 425 | PF00595 | 0.481 |
LIG_SH2_CRK | 229 | 233 | PF00017 | 0.308 |
LIG_SH2_CRK | 347 | 351 | PF00017 | 0.365 |
LIG_SH2_NCK_1 | 212 | 216 | PF00017 | 0.421 |
LIG_SH2_SRC | 229 | 232 | PF00017 | 0.268 |
LIG_SH2_STAT5 | 249 | 252 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 340 | 343 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 372 | 375 | PF00017 | 0.524 |
LIG_SH2_STAT5 | 380 | 383 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.521 |
LIG_SH3_3 | 218 | 224 | PF00018 | 0.429 |
LIG_WRC_WIRS_1 | 404 | 409 | PF05994 | 0.490 |
MOD_CDC14_SPxK_1 | 160 | 163 | PF00782 | 0.544 |
MOD_CDK_SPxK_1 | 157 | 163 | PF00069 | 0.551 |
MOD_CDK_SPxxK_3 | 152 | 159 | PF00069 | 0.492 |
MOD_CDK_SPxxK_3 | 275 | 282 | PF00069 | 0.519 |
MOD_CK1_1 | 182 | 188 | PF00069 | 0.256 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.596 |
MOD_CK2_1 | 36 | 42 | PF00069 | 0.596 |
MOD_CMANNOS | 76 | 79 | PF00535 | 0.397 |
MOD_Cter_Amidation | 137 | 140 | PF01082 | 0.732 |
MOD_Cter_Amidation | 62 | 65 | PF01082 | 0.403 |
MOD_GlcNHglycan | 126 | 130 | PF01048 | 0.561 |
MOD_GlcNHglycan | 136 | 139 | PF01048 | 0.703 |
MOD_GlcNHglycan | 181 | 184 | PF01048 | 0.264 |
MOD_GlcNHglycan | 270 | 273 | PF01048 | 0.643 |
MOD_GlcNHglycan | 282 | 285 | PF01048 | 0.730 |
MOD_GlcNHglycan | 328 | 331 | PF01048 | 0.411 |
MOD_GSK3_1 | 127 | 134 | PF00069 | 0.673 |
MOD_GSK3_1 | 178 | 185 | PF00069 | 0.256 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.570 |
MOD_GSK3_1 | 403 | 410 | PF00069 | 0.515 |
MOD_GSK3_1 | 415 | 422 | PF00069 | 0.462 |
MOD_LATS_1 | 201 | 207 | PF00433 | 0.322 |
MOD_LATS_1 | 268 | 274 | PF00433 | 0.505 |
MOD_LATS_1 | 305 | 311 | PF00433 | 0.701 |
MOD_N-GLC_1 | 122 | 127 | PF02516 | 0.692 |
MOD_N-GLC_1 | 90 | 95 | PF02516 | 0.544 |
MOD_NEK2_1 | 202 | 207 | PF00069 | 0.316 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.373 |
MOD_NEK2_1 | 387 | 392 | PF00069 | 0.315 |
MOD_NEK2_1 | 403 | 408 | PF00069 | 0.348 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.530 |
MOD_PIKK_1 | 372 | 378 | PF00454 | 0.478 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.270 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.322 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.527 |
MOD_PKA_2 | 367 | 373 | PF00069 | 0.455 |
MOD_PKA_2 | 378 | 384 | PF00069 | 0.326 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.506 |
MOD_Plk_1 | 419 | 425 | PF00069 | 0.435 |
MOD_Plk_4 | 183 | 189 | PF00069 | 0.256 |
MOD_ProDKin_1 | 127 | 133 | PF00069 | 0.713 |
MOD_ProDKin_1 | 152 | 158 | PF00069 | 0.547 |
MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.400 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.434 |
MOD_ProDKin_1 | 275 | 281 | PF00069 | 0.565 |
MOD_ProDKin_1 | 415 | 421 | PF00069 | 0.474 |
TRG_DiLeu_BaLyEn_6 | 309 | 314 | PF01217 | 0.599 |
TRG_ENDOCYTIC_2 | 199 | 202 | PF00928 | 0.290 |
TRG_ENDOCYTIC_2 | 229 | 232 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 340 | 343 | PF00928 | 0.386 |
TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.376 |
TRG_ER_diArg_1 | 13 | 15 | PF00400 | 0.380 |
TRG_ER_diArg_1 | 265 | 267 | PF00400 | 0.462 |
TRG_ER_diArg_1 | 44 | 47 | PF00400 | 0.410 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.284 |
TRG_Pf-PMV_PEXEL_1 | 51 | 55 | PF00026 | 0.372 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I045 | Leptomonas seymouri | 63% | 72% |
A0A0S4IVC3 | Bodo saltans | 49% | 94% |
A0A1X0NWZ9 | Trypanosomatidae | 56% | 89% |
A0A422MX57 | Trypanosoma rangeli | 55% | 90% |
A4HCU4 | Leishmania braziliensis | 83% | 100% |
C9ZV46 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 58% | 89% |
Q4QB89 | Leishmania major | 92% | 100% |
V5ARP5 | Trypanosoma cruzi | 55% | 89% |